Candidate coronavirus vaccines show promising results in early animal testing
A candidate vaccine that could provide protection against the COVID-19 virus and other coronaviruses has shown promising results in early animal testing.
The candidate coronavirus vaccines, created by Virginia Tech s University Distinguished Professor X.J. Meng and UVA Health s Professor Steven L. Zeichner, prevented pigs from being becoming ill with a pig coronavirus, porcine epidemic diarrhea virus (PEDV).
The researchers have recently published their findings in the
Proceedings of the National Academy of Sciences.
The candidate vaccine was developed using an innovative vaccine platform targeting a highly conserved genomic region of coronaviruses. The new vaccine platform utilizes a genome-reduced bacteria to express the coronavirus vaccine antigen on its surface. Such a vaccine platform can be manufactured with low cost in existing facilities around the world, which could meet the pandemic demand.
E-Mail
IMAGE: X.J. Meng, University Distinguished Professor in the Virginia-Maryland College of Veterinary Medicine and founding director of the new center tackling infectious disease in the Fralin Life Sciences Institute at Virginia. view more
Credit: Virginia Tech
A candidate vaccine that could provide protection against the COVID-19 virus and other coronaviruses has shown promising results in early animal testing.
The candidate coronavirus vaccines, created by Virginia Tech s University Distinguished Professor X.J. Meng and UVA Health s Professor Steven L. Zeichner, prevented pigs from being becoming ill with a pig coronavirus, porcine epidemic diarrhea virus (PEDV).
The researchers have recently published their findings in the
Primary Care Providers Could Be Key To COVID19 Vaccine Rollout In Appalachian Communities wvpublic.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wvpublic.org Daily Mail and Mail on Sunday newspapers.
Researchers study how social media misinformation influences vaccine readiness in Appalachia
The saying goes, You can t believe everything you find on the Internet. As simple as that sounds, navigating social media can often blur the line between reality and fantasy. This proves especially difficult when trying to fight a global pandemic.
Researchers at Virginia Tech are now looking into how social media misinformation influences people s intention to receive the COVID-19 vaccine, especially those within the Appalachian region, with help from a grant funded by the Fralin Life Sciences Institute and the Data and Decisions Destination Area. There is evidence to suggest that Appalachia - our community - may be particularly vulnerable to misinformation about the vaccine, said Michelle Rockwell, lead investigator on the grant and research associate for Carilion Clinic and research assistant professor with the Fralin Life Sciences Institute at Virginia Tech. We d like to improve un